Purpose Umeclidinium/vilanterol (UMEC/VI) is a novel fixed dose combination of a long-acting muscarinic receptor antagonist (LAMA) and a long-acting beta 2 receptor antagonist (LABA) agent. This analysis evaluated the incremental cost-effectiveness ratio (ICER) of UMEC/VI compared with tiotropium (TIO), from the Spanish National Health System (NHS) perspective.
https://www.researchgate.net/publication/291174641_Cost-effectiveness_of_combination_therapy_umeclidiniumvilanterol_versus_tiotropium_in_symptomatic_COPD_Spanish_patients
Umeclidinium inhalation powder (Incruse Ellipta) is a long-acting anticholinergic medi-cation labeled for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis.1 Drug Dosage Dose form Cost* Umeclidinium (Incruse Ellipta) One inhalation (62.5 mcg)
https://www.aafp.org/afp/2017/0115/p120.pdf
Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients. 1  Abstract. 2  Fulltext. 3  Metrics. 4  Get Permission.
https://www.dovepress.com/cost-effectiveness-of-combination-therapy-umeclidiniumvilanterol-versu-peer-reviewed-fulltext-article-COPD
The average price of umeclidinium is $315 per month. It is less expensive than other long-acting anticholinergic inhalers (e.g., tiotro-pium, $360) and long-acting beta agonists (e.g., salmeterol [Serevent Diskus], $340). However, umeclidinium may be a higher-tier medication on certain health plans (typically tier 3 or 4), resulting in a higher co-pay, and it is not covered by all insurance plans. SIMPLICITY The recommended dosage of umeclidinium is one 62.5-mcg inhalation daily. The admin-istration device is preloaded with blisters
https://www.aafp.org/afp/2017/0115/p120.pdf
Umeclidinium is an easy-to-use, once-daily, well-tolerated, and relatively low-cost anti-cholinergic agent for maintenance therapy in patients with moderate to severe COPD. It is at least as effective as tiotropium and improves dyspnea, quality of life, and FEV 1, although its role among the current COPD maintenance therapies is unclear. It should
https://www.aafp.org/afp/2017/0115/p120.pdf
Full-text (PDF) | Purpose Umeclidinium/vilanterol (UMEC/VI) is a novel fixed dose combination of a long-acting muscarinic receptor antagonist (LAMA) and a long-acting beta 2 receptor antagonist (LABA) agent. This analysis evaluated the incremental cost-effectiveness ratio (ICER) of UMEC/VI compare...
https://www.researchgate.net/publication/291174641_Cost-effectiveness_of_combination_therapy_umeclidiniumvilanterol_versus_tiotropium_in_symptomatic_COPD_Spanish_patients
Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients. Purpose: Umeclidinium/vilanterol (UMEC/VI) is a novel fixed dose combination of a long-acting muscarinic receptor antagonist (LAMA) and a long-acting beta 2 receptor antagonist (LABA) agent.
https://www.dovepress.com/cost-effectiveness-of-combination-therapy-umeclidiniumvilanterol-versu-peer-reviewed-fulltext-article-COPD
with umeclidinium alone are lacking.3,5 There is no research on umeclidinium’s long-term effects on frequency of exacer-bations, hospitalizations, and mortality in patients with COPD, and umeclidinium has not been studied in patients with asthma. PRICE The average price of umeclidinium is $315 per month. It is less expensive than other long-
https://www.aafp.org/afp/2017/0115/p120.pdf
Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapy over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicenter, blinded, randomized controlled trials.
https://www.dovepress.com/cost-effectiveness-of-combination-therapy-umeclidiniumvilanterol-versu-peer-reviewed-fulltext-article-COPD
Abbreviations: UMEC/VI, umeclidinium and vilanterol; TIO, tiotropium; QALY, quality-adjusted life years; ICER, incremental cost-effectiveness ratio.
https://www.researchgate.net/publication/291174641_Cost-effectiveness_of_combination_therapy_umeclidiniumvilanterol_versus_tiotropium_in_symptomatic_COPD_Spanish_patients
umeclidinium cost
The average price of umeclidinium is $315 per month.